4'-Methoxy-α-pyrrolidinopropiophenone

From Self-sufficiency
Revision as of 19:26, 23 August 2010 by ChemNerd (Talk)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
4'-Methoxy-α-pyrrolidinopropiophenone
250px
Systematic (IUPAC) name
(RS)-1-(4-methoxyphenyl)-2-(1-pyrrolidinyl)-1-propanone
Identifiers
PubChem CID 6430836
Chemical data
Formula C14H19NO2
Molar mass 233.305 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

4'-Methoxy-α-pyrrolidinopropiophenone (MOPPP) is a stimulant drug. It is structurally related to α-PPP in the same way that PMA is related to amphetamine: a methoxy group has been added to the 4-position on the phenyl ring. MOPPP was sold in Germany as a designer drug in the late 1990s and early 2000s,[1][2][3] along with a number of other pyrrolidinophenone derivatives,[4][5] although it has never achieved the same international popularity as its better-known relations α-PPP and MDPV.

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


  1. Springer D, Fritschi G, Maurer HH. Metabolism and toxicological detection of the new designer drug 4'-methoxy-alpha-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry. Journal of Chromatography B. Analytical Technologies in the Biomedical and Life Sciences. 2003 Aug 15;793(2):331-42. PMID 12906908
  2. Springer D, Staack RF, Paul LD, Kraemer T, Maurer HH. Identification of cytochrome P450 enzymes involved in the metabolism of 4'-methoxy-alpha-pyrrolidinopropiophenone (MOPPP), a designer drug, in human liver microsomes. Xenobiotica. 2003 Oct;33(10):989-98. PMID 14555336
  3. Springer D, Fritschi G, Maurer HH. Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry. Journal of Chromatography B. Analytical Technologies in the Biomedical and Life Sciences. 2003 Nov 5;796(2):253-66. PMID 14581066
  4. Maurer HH, Kraemer T, Springer D, Staack RF. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Therapeutic Drug Monitoring. 2004 Apr;26(2):127-31. PMID 15228152
  5. Staack RF, Maurer HH. Metabolism of designer drugs of abuse. Current Drug Metabolism. 2005 Jun;6(3):259-74. PMID 15975043